| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/12/2002 | WO2002070703A2 Cell visual characteristic-modifying sequences |
| 09/12/2002 | WO2002070701A2 Novel human gnrh receptor |
| 09/12/2002 | WO2002070696A2 Cd109 nucleic acid molecules polypeptides and methods of use |
| 09/12/2002 | WO2002070687A1 Highly sensitive nucleic acid hybridization method and gene analysis method by using the same |
| 09/12/2002 | WO2002070681A1 Protein c variants |
| 09/12/2002 | WO2002070679A2 Peptide fragments, derived from human telomerase reverse transcriptase |
| 09/12/2002 | WO2002070669A2 Secreted proteins |
| 09/12/2002 | WO2002070663A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 09/12/2002 | WO2002070662A2 Three hybrid assay system |
| 09/12/2002 | WO2002070658A2 Compositions and methods for increasing amino acid absorption in mammals |
| 09/12/2002 | WO2002070657A2 93870, a human g-protein coupled receptor and uses therefor |
| 09/12/2002 | WO2002070655A2 Mouse cytokine receptor |
| 09/12/2002 | WO2002070563A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070562A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070561A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070560A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070559A2 Nuclear hormone receptor ligand binding domains |
| 09/12/2002 | WO2002070558A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070557A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070556A1 POLYPEPTIDE OF A P53 PROTEIN-SPECIFIC MURINE Α/β T-CELL RECEPTOR, NUCLEIC ACIDS CODING THEREFOR AND USE THEREOF |
| 09/12/2002 | WO2002070555A2 Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 09/12/2002 | WO2002070553A1 Tumour peptide antigen produced from human mdm2 proto-oncogene |
| 09/12/2002 | WO2002070552A2 POLYPEPTIDE FROM A HDM2 PROTEIN SPECIFIC MURINE Α/β T-CELL RECEPTORS, NUCLEIC ACIDS CODING FOR THE ABOVE AND USE THEREOF |
| 09/12/2002 | WO2002070020A2 Polymer precursors of radiolabeled compounds, and methods of making and using the same |
| 09/12/2002 | WO2002070018A2 Tetradentate peptide-chelate conjugates for colorectal cancer diagnosis |
| 09/12/2002 | WO2002070011A2 Treatment of ppar mediated diseases |
| 09/12/2002 | WO2002070006A2 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
| 09/12/2002 | WO2002070003A1 Altered peptide ligands |
| 09/12/2002 | WO2002069992A1 Plant extracts and compositions comprising extracellular protease inhibitors |
| 09/12/2002 | WO2002069908A2 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 09/12/2002 | WO2002069907A2 Anti-neovasculature preparations for cancer |
| 09/12/2002 | WO2002069899A2 Methods and compositions for the treatment and prevention of smooth muscle cell proliferation |
| 09/12/2002 | WO2002069896A2 Connexin enhances chemotherapy-induced apoptosis in human cancer cells inhibiting tumor cell proliferation |
| 09/12/2002 | WO2002069890A2 Methods of identifying agents affecting atrophy and hypertrophy |
| 09/12/2002 | WO2002069886A2 Modified proteins, designer toxins, and methods of making thereof |
| 09/12/2002 | WO2002062851A8 Conformationally abnormal forms of tau proteins and specific antibodies thereto |
| 09/12/2002 | WO2002055733A3 Method for detecting living microorganisms |
| 09/12/2002 | WO2002052274A3 Screening method based on tsap6 binding partners |
| 09/12/2002 | WO2002052012A3 Sugar beet genes involved in stress tolerance |
| 09/12/2002 | WO2002049576A3 Fab i and inhibition of apicomplexan parasites |
| 09/12/2002 | WO2002043779A3 Use of acacia gum (arabic gum) to isolate and preserve biological material |
| 09/12/2002 | WO2002042771A3 Detection of binding reactions using catalytic electrochemical labels |
| 09/12/2002 | WO2002040500A3 Method of prognosis and diagnosis of congestive heart failure |
| 09/12/2002 | WO2002031478A3 Methods and devices for assays using analyte-binding partners |
| 09/12/2002 | WO2002028997A3 Methods of isolating bipotent hepatic progenitor cells |
| 09/12/2002 | WO2002027015A3 Assays for identifying receptors having alterations in signaling |
| 09/12/2002 | WO2002016410A3 Peptide selection method |
| 09/12/2002 | WO2002014369A3 Human kininogen d5 domain polypeptides and their use |
| 09/12/2002 | WO2001086295A3 Detection of antibodies to gangliosides |
| 09/12/2002 | WO2001081626A3 Methods for clinical diagnosis |
| 09/12/2002 | WO2001077684A3 Proteomic analysis using activity-based probe libraries |
| 09/12/2002 | WO2001077335A3 Listeria monocytogenes genome, polypeptides and uses |
| 09/12/2002 | WO2001073118A3 Hybridisation beacon and method of rapid sequence detection and discrimination |
| 09/12/2002 | WO2001071346A3 Binding compounds for cc chemokine receptor 5 and methods for identifying them |
| 09/12/2002 | WO2001050127A9 Screening using biological target molecules with metal-ion binding sites |
| 09/12/2002 | WO2001046686A9 Chromatography material and a method using same |
| 09/12/2002 | WO2001042467A3 Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 09/12/2002 | WO2001040804A9 Clearance of aberrant protein in correlation with disease |
| 09/12/2002 | WO2001040519A3 Methods for identifying modulators for balance related disorders |
| 09/12/2002 | WO2001035811A3 Methods of diagnosing and determining prognosis of breast cancer |
| 09/12/2002 | WO2001035102A3 Diagnosis and treatment of malignant neoplasms |
| 09/12/2002 | WO2001030848A3 Nucleic acids of the human abc1 gene and applications thereof |
| 09/12/2002 | WO2001020034A3 Methods and compositions for the screening of cell cycle modulators |
| 09/12/2002 | WO2001018235A3 Lateral flow device with metal oxide indicator and assay method employing same |
| 09/12/2002 | WO2001016582A9 In situ methods for measuring the release of a substance from a dosage form |
| 09/12/2002 | WO2001016372A9 Methods of immobilizing ligands on solid supports and apparatus and methods of use therefor |
| 09/12/2002 | WO2001012210A9 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase raf and ras |
| 09/12/2002 | WO2001009192A9 Human monoclonal antibodies to prostate specific membrane antigen |
| 09/12/2002 | WO2001006252A3 Prediction of hepatic failure following hepatitis c |
| 09/12/2002 | WO2001006229A3 Analytical sampling device |
| 09/12/2002 | WO2001002609A3 Method of identifying toxic agents using differential gene expression |
| 09/12/2002 | WO2000075644A9 Sensor platform and method for analysing multiple analytes |
| 09/12/2002 | WO2000075167A3 Phosphorylation assays |
| 09/12/2002 | WO2000073801A3 Breast, gastric and prostate cancer associated antigens and uses therefor |
| 09/12/2002 | WO2000067792A9 Monoclonal antibody directed against cells of human renal cell carcinoma |
| 09/12/2002 | WO2000066727A9 Tumour-associated antigen |
| 09/12/2002 | WO2000053616A3 Nucleotides and polynucleotides immobilised on a solid support via a disulphide linkage |
| 09/12/2002 | US20020129395 Compositions to identify swine genetically resistant to F18 E. coli associated diseases |
| 09/12/2002 | US20020129391 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease |
| 09/12/2002 | US20020129388 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of atherosclerosis |
| 09/12/2002 | US20020129386 High estrogen-sensitive medaka fish |
| 09/12/2002 | US20020129385 Medthods for improving long-term memory storage and retrieval |
| 09/12/2002 | US20020128782 Technique for rapid prediction of long-term hydrophobic organic contaminant desorption rates |
| 09/12/2002 | US20020128781 Statistical combining of cell expression profiles |
| 09/12/2002 | US20020128585 Medical system, method and apparatus employing mems |
| 09/12/2002 | US20020128476 Inhibitors of cysteine protease |
| 09/12/2002 | US20020128465 Charge tags and the separation of nucleic acid molecules |
| 09/12/2002 | US20020128464 Nucleotide sequences coding enzymatic polypeptide for use in generating geetically engineered herbicide sensitive plants |
| 09/12/2002 | US20020128454 CACNGLIKE3 polypeptides |
| 09/12/2002 | US20020128451 Phthalamide-lanthanide complexes for use as luminescent markers |
| 09/12/2002 | US20020128444 Controling abberant inflamatory response; obtain animal, incubate with modulator of inflammation, monitor animal for adjustment in inflammatory response |
| 09/12/2002 | US20020128443 Polynucleotides encoding thrombin receptor homologs |
| 09/12/2002 | US20020128437 Polypeptide for use in the detection of bactericides and prevention, detect and treatment of infections |
| 09/12/2002 | US20020128381 Polysaccharide having an aminated keto-carboxy group e.g. derived from KDO (2-keto-3-deoxy-D-manno-octonic acid)) |
| 09/12/2002 | US20020128319 Abeta 42 lowering agents |
| 09/12/2002 | US20020128277 Modulators of KCNQ potassium channels and use thereof in treating migraine and mechanistically related diseases |
| 09/12/2002 | US20020128276 Administering an estrogen agonist/ antagonist; lowering vaginal pH; treating an urinary tract infection; treating vaginal dryness, itching, undesired spasms, and vaginitis; treating undesired urinary frequency or incontinence |
| 09/12/2002 | US20020128234 Multifunctional polymeric surface coatings in analytic and sensor devices |
| 09/12/2002 | US20020128203 Methods of identifying inhibitory compounds and uses thereof |
| 09/12/2002 | US20020128200 Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen tyrosinase derived peptides, and methods for treating said individuals |